NeuroAudit

NeuroAudit is a technology company focused on psychoacoustics neurotechnology. It specializes in a non-invasive brain stimulation platform that uses an intelligent patch to deliver focused ultrasound stimulation. This innovative approach aims to enhance cognitive function and address brain disorders such as Alzheimer's disease and dementia. Founded in 2016, NeuroAudit is at the seed stage with an alpha product ready for market introduction. The company's core product targets the auditory cortex, using gamma frequency sound waves to modulate brain activity. This technology offers therapeutic benefits for patients with cognitive disorders, improving hearing, orientation, and cognitive function. Additionally, it has potential applications in treating depression and other brain diseases, providing an alternative to traditional drug therapies and invasive procedures. NeuroAudit primarily serves the medical market, focusing on the growing demographic of older adults facing cognitive decline. The company is financially stable, self-funded, and has received recognition for its innovative solutions. As it prepares to scale its market presence, NeuroAudit is positioned to make a significant impact in the field of neurotechnology.

• Employees 3
• Founded 2016